CENV3 vaccine (National Liver Institute, Egypt)
N/A
Report date: 2024/12/11 10:05:04
Base Information
Drug NameCENV3 vaccine (National Liver Institute, Egypt)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Liver Institute, Egypt
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Liver Institute, Egypt
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A